Brogna Barbara, Romano Annamaria, Tibullo Loredana, Montuori Mariagrazia, Nunziata Mariagrazia, Russo Giuseppe, Musto Lanfranco A
Department of Radiology, San Giuseppe Moscati Hospital Avellino, Avellino, Italy.
Department of Pneumology, San Giuseppe Moscati Hospital Avellino, Avellino, Italy.
Acta Radiol Open. 2021 Jul 30;10(7):20584601211028149. doi: 10.1177/20584601211028149. eCollection 2021 Jul.
Hemothorax (HT) and pulmonary hematoma represent rare complications of anticoagulant therapy. We present a rare case of a 53-year-old man with COVID-19 pneumonia who showed, in a follow-up computed tomography (CT) scan 13 days after hospitalization, a left HT and a small hyperdense area in a subpleural location and compatible with a small subpleural hematoma. This patient was being treated with a subcutaneous administration of low-molecular-weight heparin (100UI/kg/BID). No vascular malformations were visualized on the CT pulmonary angiography. Herein, we report the first case of both a spontaneous HT and a lung subpleural hematoma in a COVID-19 patient, probably caused by anticoagulant therapy.
血胸（HT）和肺血肿是抗凝治疗罕见的并发症。我们报告了一例罕见病例，一名53岁的新冠肺炎男性患者，在住院13天后的随访计算机断层扫描（CT）中显示左侧血胸以及胸膜下位置有一个小的高密度区域，符合小的胸膜下血肿表现。该患者正在接受皮下注射低分子量肝素（100UI/kg/每日两次）治疗。CT肺血管造影未发现血管畸形。在此，我们报告了首例新冠肺炎患者出现自发性血胸和肺胸膜下血肿的病例，可能由抗凝治疗引起。
